ICMR-National Institute of Cholera and Enteric Diseases

आई सी एम आर - राष्ट्रीय कॉलरा और आंत्र रोग संस्थान

Department of Health Research, Ministry of Health and Family Welfare, Government of India
स्वास्थ्य अनुसंधान विभाग, स्वास्थ्य और परिवार कल्याण मंत्रालय, भारत सरकार
WHO Collaborating Centre For Research and Training On Diarrhoeal Diseases


  • Patel K, Nayak B, Rana S, Krishnan P, Tandale BV, Basak S, Sinha A, Kumar MS, Borah P, Singh H, Gupta N, Dutta S, Mohan A, Das MK, Landge Y, Ganguly B, Devi U, Pati S, Palo SK. Enablers and barriers towards ensuring routine immunization services during the COVID-19 pandemic: findings from a qualitative study across five different states in India. Trans R Soc Trop Med Hyg. 2022 Mar 2:trac011. doi: 10.1093/trstmh/trac011. Epub ahead of print.
  • Sarkar R, Saha R, Mallick P, Sharma R, Kaur A, Dutta S, et al. Emergence of a novel SARS-CoV-2 Pango lineage B.1.1.526 in West Bengal, India. J Infect Public Health. 2022 Jan 1;15(1):42-50.
  • Ghosh M, Basak S, Dutta S. Underlying selection for the diversity of spike protein sequences of SARS-CoV-2. IUBMB Life. 2022;74(3):213-20.
  • Sarkar MA, Ozair A, Singh KK, Subash NR, Bardhan M, Khulbe Y. SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health. Ann Glob Health. 2021 Dec 10;87(1):124.
  • Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, et al. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet. 2021 Nov 11;398(10317):2173-84.
  • Gupta N, Kaur H, Yadav PD, Mukhopadhyay L, Sahay RR, Kumar A, et al. Clinical characterization and genomic analysis of samples from covid-19 breakthrough infections during the second wave among the various states of india. Viruses. 2021;13(9).
  • Murhekar MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, Santhosh Kumar M, et al. (2021) Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study. PLOS Medicine 18(12): e1003877.
  • Tewari DN, Chakrabarti AK, Dutta S. Prospect of Ion Channel Inhibitors and Cholesterol Lowering Drugs to Combat COVID-19. J Emerg Dis Virol. 2021;6(2):1-3.
  • Yadav PD, Nyayanit DA, Majumdar T, Patil S, Kaur H, Gupta N, et al. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India. Viruses. 2021;13(5):925.
  • Sarkar A, Chakrabarti AK, Dutta S. Covid-19 infection in India: A comparative analysis of the second wave with the first wave. Pathogens. 2021 Sep 21;10(9):1222.
  • Bhatta M, Nandi S, Dutta S, Saha MK. Coronavirus (SARS-CoV-2): a systematic review for potential vaccines. Hum Vaccin Immunother. 2021 Feb 5:1-18.
  • Sarkar R, Mitra S, Chandra P, Saha P, Banerjee A, Dutta S, et al. Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations. Arch Virol. 2021 Jan 19;166(3):801-12.
  • Biswas S, Ghosh P, Chakraborty D, Chatterjee A, Dutta S, Saha MK. COVID-19 Infection: Data Gaps for Diagnostic Laboratory Preparedness and Tasks on Hand. Viral Immunol. 2021;34(3):158-64.
  • Murhekar M V., Bhatnagar T, Selvaraju S, Saravanakumar V, Thangaraj JWV, Shah N, et al. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey. Lancet Glob Heal. 2021 Mar 1;9(3):e257-66.
  • Murhekar M V., Bhatnagar T, Thangaraj JWV, Saravanakumar V, Kumar MS, Selvaraju S, et al. SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021. Int J Infect Dis. 2021;108:145-55.
  • Maitra A, Sarkar MC, Raheja H, Biswas NK, Chakraborti S, Singh AK, et al. Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility. J Biosci. 2020;45(1):1-18.
  • Gupta N, Potdar V, Praharaj I, Giri S, Sapkal G, Yadav P, et al. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020;151(2):216-25.
  • Biswas A, Bhattacharjee U, Chakrabarti AK, Tewari DN, Banu H, Dutta S. Emergence of Novel Coronavirus and COVID-19: whether to stay or die out? Crit Rev Microbiol. 2020;46(2):182-93.
  • Banerjee A, Sarkar R, Mitra S, Lo M, Dutta S, Chawla-Sarkar M. The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India. JMIR Bioinforma Biotechnol. 2020;1(1):e20735.
  • Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19. Indian J Med Res. 2020 May;151(5):459-467.
  • Kumar M, Bhatnagar T, Manickam P, Kumar V, Rade K, Shah N, et al. National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance. Indian J Med Res. 2020 May 1;151(5):419-23.
  • Chakraborty D, Debnath F, Biswas S, Bhatta M, Ganguly S, Deb AK, et al. Exploring Repurposing Potential of Existing Drugs in the Management of COVID-19 Epidemic: A Critical Review. J Clin Med Res. 2020;12(8):463-71.
  • Murhekar M V., Bhatnagar T, Selvaraju S, Rade K, Saravanakumar V, Thangaraj JWV, et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res. 2020;152(1):48-60.